Publikationen in Zusammenarbeit mit Forschern von Institució Catalana de Recerca i Estudis Avançats (11)

2023

  1. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  2. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)

    Bone Marrow Transplantation

  3. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

    ESMO Open, Vol. 8, Núm. 3

2022

  1. Corrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 29 suppl. 4 (2018) v238–iv255](S0923753419317119)(10.1093/annonc/mdy308)

    Annals of Oncology

  2. Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer

    Gut, Vol. 71, Núm. 10, pp. 2069-2080

2020

  1. Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma

    Genome Research, Vol. 30, Núm. 9, pp. 1217-1227

  2. Intratumoral heterogeneity and clonal evolution in liver cancer

    Nature Communications, Vol. 11, Núm. 1

  3. Milestones in the pathogenesis and management of primary liver cancer

    Journal of Hepatology

2018

  1. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

    Oncogene, Vol. 37, Núm. 27, pp. 3740-3752

  2. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Annals of Oncology, Vol. 29, pp. iv238-iv255

2016

  1. Hepatocellular carcinoma

    Nature Reviews Disease Primers, Vol. 2